2 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Monocytic Leukemia: new trials by email Literature Review of Monocytic Leukemia trials Research Report on Monocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia Venetoclax, Azacitidine, Mitoxantrone - Leukemia, Myeloid Leukemia | Phase 1 | Recruiting | University of Colorado, Denver | 30 | 2024-07-21 | 2026-01-15 |
| Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation Enasidenib mesylat dose escalation - Leukemia, Leukemia, Myeloid | Phase 1 / Phase 2 | Completed | Tian Yi Zhang | 17 | 2022-01-12 | 2026-09-03 |
| FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia Daratumumab/rHuPH20, FT538, Fludarabine - Acute Myeloid Leukemia, Myeloid Leukemia | Phase 1 | Completed | Masonic Cancer Center, University of Minnesota | 9 | 2021-11-03 | 2024-10-24 |
Leukemia, Monocytic, Acute (3) · Leukemia, Myeloid (3) · Leukemia (2) · Leukemia, Myeloid, Acute (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Leukemia, Myeloid, Acute (2) · Leukemia (1)
Azacitidine (1) · Cyclophosphamide (1) · Mitoxantrone (1) · daratumumab (1) · enasidenib (1) · fludarabine (1) · fludarabine phosphate (1) · venetoclax (1)
Masonic Cancer Center, University of Minnesota (1) · Tian Yi Zhang (1) · University of Colorado, Denver (1)
United States (3)
Andrew Kent, MD, PhD (1) · Joseph Maakaron, MD (1) · Tian Yi Zhang, MD (1)